These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3585 related items for PubMed ID: 9328449

  • 1. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
    Lazzari L, Henschler R, Lecchi L, Rebulla P, Mertelsmann R, Sirchia G.
    Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
    [Abstract] [Full Text] [Related]

  • 4. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
    Andrews RG, Briddell RA, Hill R, Gough M, McNiece IK.
    Stem Cells; 1999 Jan; 17(4):210-8. PubMed ID: 10437984
    [Abstract] [Full Text] [Related]

  • 5. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [Abstract] [Full Text] [Related]

  • 6. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
    Srour EF, Bregni M, Traycoff CM, Agüero B, Kosak ST, Hoffman R, Siena S, Gianni AM.
    Blood Cells Mol Dis; 1996 Dec; 22(1):68-81. PubMed ID: 8807087
    [Abstract] [Full Text] [Related]

  • 7. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.
    Li K, Li CK, Chuen CK, Tsang KS, Fok TF, James AE, Lee SM, Shing MM, Chik KW, Yuen PM.
    Eur J Haematol; 2005 Feb; 74(2):128-35. PubMed ID: 15654904
    [Abstract] [Full Text] [Related]

  • 8. Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts.
    Ahmed N, Khokher MA, Hassan HT.
    Stem Cells; 1999 Feb; 17(2):92-9. PubMed ID: 10195569
    [Abstract] [Full Text] [Related]

  • 9. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6.
    Kobari L, Giarratana MC, Poloni A, Firat H, Labopin M, Gorin NC, Douay L.
    Bone Marrow Transplant; 1998 Apr; 21(8):759-67. PubMed ID: 9603398
    [Abstract] [Full Text] [Related]

  • 10. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J, Oez S, Smetak M, Kaiser G, Kappauf H, Gallmeier WM.
    Stem Cells; 1997 Apr; 15(1):18-32. PubMed ID: 9007219
    [Abstract] [Full Text] [Related]

  • 11. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L, Heimfeld S, Broxmeyer HE.
    Blood Cells; 1994 Apr; 20(2-3):436-54. PubMed ID: 7538350
    [Abstract] [Full Text] [Related]

  • 12. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
    Hagiwara T, Kodama I, Horie K, Kato T, Miyazaki H.
    Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
    [Abstract] [Full Text] [Related]

  • 13. Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macrophage progenitors.
    Rasko JE, O'Flaherty E, Begley CG.
    Stem Cells; 1997 Mar; 15(1):33-42. PubMed ID: 9007220
    [Abstract] [Full Text] [Related]

  • 14. Platelet-derived growth factor enhances ex vivo expansion of megakaryocytic progenitors from human cord blood.
    Su RJ, Li K, Yang M, Zhang XB, Tsang KS, Fok TF, Li CK, Yuen PM.
    Bone Marrow Transplant; 2001 May; 27(10):1075-80. PubMed ID: 11438824
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 16. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
    Traycoff CM, Abboud MR, Laver J, Clapp DW, Srour EF.
    Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
    [Abstract] [Full Text] [Related]

  • 17. In vitro expansion of CD34+/CD41+ cells from human peripheral blood CD34+/CD41- cells: role of cytokines for in vitro proliferation and differentiation of megakaryocytic progenitors.
    Koizumi K, Sawada K, Yamaguchi M, Notoya A, Tarumi T, Takano H, Fukada Y, Nishio M, Katagiri E, Yasukouchi T, Sato N, Sekiguchi S, Koike T.
    Exp Hematol; 1998 Nov; 26(12):1140-7. PubMed ID: 9808053
    [Abstract] [Full Text] [Related]

  • 18. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N, Koike K, Mwamtemi HH, Ito S, Kurokawa Y, Sakashita K, Kinoshita T, Higuchi T, Takeuchi K, Shiohara M, Kamijo T, Higuchi Y, Miyazaki H, Kato T, Kobayashi M, Miyake M, Yasui K, Komiyama A.
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [Abstract] [Full Text] [Related]

  • 19. Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.
    Murray LJ, Luens KM, Estrada MF, Bruno E, Hoffman R, Cohen RL, Ashby MA, Vadhan-Raj S.
    Exp Hematol; 1998 Mar; 26(3):207-16. PubMed ID: 9502616
    [Abstract] [Full Text] [Related]

  • 20. Thrombopoietin combined with early-acting growth factors effectively expands human hematopoietic progenitor cells in vitro.
    Hunnestad JA, Steen R, Tjønnfjord GE, Egeland T.
    Stem Cells; 1999 Mar; 17(1):31-8. PubMed ID: 10215399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 180.